HuagongsheHuagongshe Chemistry Print Report · For research reference only
4,4,5,5-Tetramethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolane → 4-[4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-pyrimidin-2-yl]piperazine-1-carboxylic acid tert-butyl ester
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4,4,5,5-Tetramethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolane | HCID 11243929 | — |
| Reactant | tert-Butyl 4-(4-chloropyrimidin-2-yl)piperazine-1-carboxylate | HCID 46738270 | — |
| Product | 4-[4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-pyrimidin-2-yl]piperazine-1-carboxylic acid tert-butyl ester | HCID 67248680 | — |
Reaction Steps
The preparation is carried out analogously to FS 103 starting from 4-(4-chloropyrimidin-2-yl)piperazine-1-carboxylic acid tert-butyl ester (preparation analogous to US 2005/176722) and 4,4,5,5-tetramethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolane.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09062015B2 |
| Source dataset | uspto-grants-2015_06 |
| ORD ID | ord-4ca2c8e74a624908b27798dad5c86c15 |
| Source note | uspto-grants-2015_06 |